By Counterforce Health Team in Alecensa (alectinib) —

Get Alecensa (Alectinib) Covered by Blue Cross Blue Shield in New Jersey: Complete Guide to Prior Authorization and Appeals

Answer Box: Quick Path to Alecensa Coverage in New Jersey

Is Alecensa covered by Blue Cross Blue Shield in New Jersey? Yes, with prior authorization for ALK-positive non-small cell lung cancer. Fastest approval path: 1) Confirm ALK testing results are documented, 2) Submit complete prior authorization through your oncologist with surgical/treatment history, 3) Use Horizon BCBS's online portal or call 1-800-370-5088 for status updates. Start today: Contact your oncology team to verify they have your ALK test results and complete treatment records ready for submission. Appeals through New Jersey's IHCAP program have strong success rates when proper documentation is provided.

Table of Contents

  1. Coverage Basics: Is Alecensa Covered?
  2. Prior Authorization Process
  3. Timeline and Urgency
  4. Medical Necessity Criteria
  5. Understanding Costs
  6. When Denials Happen: Appeals Process
  7. Renewal Requirements
  8. Specialty Pharmacy Requirements
  9. Troubleshooting Common Issues
  10. Frequently Asked Questions

Coverage Basics: Is Alecensa Covered?

Blue Cross Blue Shield plans in New Jersey, primarily Horizon Blue Cross Blue Shield, cover Alecensa (alectinib) for ALK-positive non-small cell lung cancer, but prior authorization is required for all uses.

Coverage at a Glance

Requirement Details Where to Find It Source
Prior Authorization Required for all indications Horizon BCBS PA List PA Requirements
ALK Testing Must be documented and positive Lab reports/pathology Medical records
Specialty Pharmacy Required dispensing channel Member portal Plan documents
Quantity Limits Typically 240 caps/30 days Formulary Plan-specific
Step Therapy May require crizotinib first PA criteria Verify with plan

Key Coverage Points:

  • Both metastatic and adjuvant (post-surgical) indications are covered
  • Requires oncology specialist prescribing
  • Must demonstrate ALK-positive mutation via approved testing
  • Surgical resection history required for adjuvant use

Prior Authorization Process

Step-by-Step: Fastest Path to Approval

1. Gather Required Documentation (Patient/Clinic - Day 1)

  • ALK testing results (FISH or next-generation sequencing)
  • Complete staging documentation
  • Surgical pathology reports (for adjuvant use)
  • Prior treatment records and outcomes

2. Oncologist Submits PA Request (Clinic - Days 1-3)

3. Plan Review Process (BCBS - Days 4-14)

  • Standard review: up to 14 business days
  • Expedited review: 72 hours if urgent medical need documented
  • May request additional clinical information

4. Approval and Specialty Pharmacy Setup (Days 15-17)

  • Approved prescriptions sent to designated specialty pharmacy
  • Patient contacted for delivery coordination
Tip: Submit requests early in the week to avoid weekend delays in processing.

Required Documentation Checklist

Clinical Evidence:

  • ✅ Positive ALK rearrangement test results
  • ✅ Pathology report confirming NSCLC diagnosis
  • ✅ Staging documentation (imaging reports)
  • ✅ Performance status assessment
  • ✅ Complete medication history

For Adjuvant Use:

  • ✅ Surgical pathology confirming complete resection
  • ✅ Post-surgical staging confirmation
  • ✅ Documentation of Stage IB-IIIA disease

Timeline and Urgency

Standard Processing Times

  • Initial PA Review: 14 business days maximum
  • Expedited Review: 72 hours (requires urgent medical justification)
  • Appeal Processing: 30 days for internal, 45 days for external review
  • Specialty Pharmacy Fulfillment: 2-3 business days after approval

When to Request Expedited Review

Request expedited processing if:

  • Disease progression is rapid
  • Patient experiencing severe symptoms
  • Delay would compromise treatment outcomes
  • Current therapy is failing or causing intolerable side effects

Contact Horizon BCBS at 1-800-370-5088 to request expedited review with clinical justification.

Medical Necessity Criteria

Core Requirements for Approval

ALK-Positive Testing:

  • Must demonstrate ALK rearrangement via FDA-approved testing
  • Acceptable methods: FISH, IHC, or next-generation sequencing
  • Results must be from certified laboratory

Disease Staging:

  • Metastatic NSCLC: Any stage with confirmed metastases
  • Adjuvant use: Stage IB-IIIA with complete surgical resection
  • Adequate performance status (typically ECOG 0-2)

Prior Treatment Documentation:

  • For metastatic disease: May require trial of preferred ALK inhibitor
  • Document reasons for therapy selection
  • Include contraindications to alternative treatments

Clinician Corner: Medical Necessity Letter Essentials

Your oncologist's letter should address:

  1. Patient's specific diagnosis with ICD-10 codes
  2. ALK testing methodology and results with lab reference
  3. Disease staging and extent with imaging correlation
  4. Prior treatments tried and outcomes including reasons for discontinuation
  5. Clinical rationale for Alecensa referencing FDA prescribing information
  6. Monitoring plan for liver function and potential side effects

Understanding Costs

Insurance Coverage Structure

With Blue Cross Blue Shield approval, Alecensa typically falls under specialty drug benefits with:

  • Coinsurance: Usually 10-30% of drug cost
  • Copayment: Fixed amount (varies by plan)
  • Deductible: May apply before coverage begins
  • Out-of-pocket maximum: Annual limit on patient costs

Financial Assistance Options

Genentech Copay Assistance:

Additional Resources:

  • Patient Access Network Foundation
  • CancerCare Co-Payment Assistance
  • State pharmaceutical assistance programs
Note: Copay assistance programs cannot be used with government insurance (Medicare, Medicaid).

When Denials Happen: Appeals Process

Common Denial Reasons and Solutions

Denial Reason How to Address Required Documentation
Missing ALK test Submit complete pathology report Lab results with methodology
Insufficient medical necessity Enhanced clinical letter Treatment history, contraindications
Step therapy not met Request exception or document failure Prior medication trials
Non-formulary status Formulary exception request Medical necessity justification

New Jersey Appeals Process

Level 1: Internal Appeal (Required First Step)

  • Timeline: Must file within 180 days of denial
  • Process: Submit through Horizon BCBS member portal or by phone
  • Decision time: 30 days for standard, 72 hours for expedited

Level 2: External Review via IHCAP

  • Operator: Maximus Federal Services manages New Jersey's Independent Health Care Appeals Program
  • Timeline: File within 4 months (180 days) of final internal denial
  • Cost: Free to patients (insurer pays all costs)
  • Success rate: External reviews favor consumers in approximately 50% of cases

How to File an External Appeal in New Jersey

  1. Complete Internal Appeals: Must exhaust Horizon BCBS internal process first
  2. Gather Documentation: Final denial letter, medical records, physician statement
  3. Submit to IHCAP: Use online portal or call 1-888-393-1062
  4. Review Process: Independent physician reviewers evaluate medical necessity
  5. Decision: Binding determination within 45 days (expedited cases much faster)
From our advocates: We've seen oncology drug appeals succeed when the clinical team provides detailed treatment rationale addressing the specific denial reason. One effective approach is having the oncologist directly reference the insurer's own medical policy criteria in their appeal letter, showing point-by-point how the patient meets each requirement.

Renewal Requirements

When to Reauthorize

  • Initial approval: Typically 12 months
  • Renewal timing: Submit 30-60 days before expiration
  • Required updates: Current labs, imaging, response assessment
  • Continued medical necessity: Document ongoing benefit and tolerability

What Changes Require New Authorization

  • Dose modifications beyond approved range
  • Treatment interruptions longer than 30 days
  • Change in diagnosis or staging
  • Switch between metastatic and adjuvant indications

Specialty Pharmacy Requirements

Why Specialty Pharmacy is Required

Alecensa requires specialty pharmacy dispensing due to:

  • High cost and specialized handling
  • Patient monitoring requirements
  • Coordination with oncology care teams
  • Insurance benefit management

Horizon BCBS Specialty Network

Common specialty pharmacies include:

  • Accredo Specialty Pharmacy
  • AllianceRx Walgreens Prime
  • CVS Specialty
  • Plan-specific contracted pharmacies

Important: Verify your specific plan's specialty pharmacy network before approval to avoid delays.

Troubleshooting Common Issues

Portal and System Problems

If the provider portal is down:

  • Call Horizon BCBS directly: 1-800-370-5088
  • Fax submissions to backup number (verify current)
  • Email submissions may be accepted for urgent cases

Missing Forms or Documents:

  • Download current PA forms from Horizon provider resources
  • Contact provider services for missing templates
  • Use generic medical necessity letter format if specific forms unavailable

Status Check Delays:

  • Allow full business days for processing
  • Weekends and holidays don't count toward review timelines
  • Expedited requests require clinical urgency documentation

Frequently Asked Questions

How long does Blue Cross Blue Shield PA take in New Jersey? Standard prior authorization review takes up to 14 business days. Expedited reviews are completed within 72 hours when urgent medical need is documented.

What if Alecensa is non-formulary on my plan? Request a formulary exception by demonstrating medical necessity and providing clinical justification for why formulary alternatives are inappropriate.

Can I request an expedited appeal? Yes, both internal appeals and external IHCAP reviews can be expedited when delay would cause serious harm to your health.

Does step therapy apply if I've failed treatments outside New Jersey? Treatment history from other states is generally accepted. Provide complete documentation of prior therapies tried and outcomes.

What happens if my appeal is denied? After exhausting internal appeals, you can file for external review through New Jersey's IHCAP program. This provides independent physician review and binding decisions.

How do I check if my oncologist is in-network? Use Horizon BCBS's provider directory online or call member services. Alecensa requires oncology specialist prescribing.

Can I fill Alecensa at my regular pharmacy? No, Alecensa must be dispensed through designated specialty pharmacies due to its classification and handling requirements.

What if I move out of New Jersey during treatment? Contact your new state's Blue Cross Blue Shield plan immediately to transfer coverage and ensure continuity of care.

Counterforce Health helps patients navigate complex prior authorization and appeals processes by turning insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and creates point-by-point rebuttals aligned to each plan's specific requirements, helping patients get faster access to needed medications like Alecensa.

For more guidance on insurance appeals and prior authorization strategies, visit www.counterforcehealth.org.

Sources and Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage varies by individual plan and circumstances. Always consult with your healthcare provider and insurance plan directly for personalized guidance. For additional help with New Jersey insurance issues, contact the NJ Department of Banking and Insurance Consumer Hotline at 1-800-446-7467.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.